SkinHealth Systems (SKIN) Other financing activities (2020 - 2024)

SkinHealth Systems (SKIN) has reported Other financing activities for 4 consecutive years, with -$302000.0 the latest figure, recorded in Q4 2024.

• On a quarterly basis, Other financing activities rose 15.17% year-over-year to -$302000.0 in Q4 2024; TTM through Dec 2024 was -$884000.0, a 51.89% decrease from a year earlier, with the FY2024 full-year figure at -$302000.0, changed N/A from the prior year.
• Other financing activities was -$302000.0 for Q4 2024 at SkinHealth Systems, up from -$356000.0 in the prior quarter.
• Over five years, Other financing activities peaked at $14.0 million in Q4 2020 and troughed at -$169.4 million in Q4 2021.
• A 4-year average of -$22.4 million and a median of -$302000.0 in 2024 frame the typical range for Other financing activities.
• Across the five-year window, Other financing activities plunged 1310.17% in 2021 and gained 15.17% in 2024, its largest moves.
• Over 4 years, Other financing activities stood at $14.0 million in 2020, then sank by 1310.17% to -$169.4 million in 2021, then soared by 99.79% to -$356000.0 in 2023, then gained by 15.17% to -$302000.0 in 2024.
• The last three Other financing activities figures came in at -$302000.0 (Q4 2024), -$356000.0 (Q4 2023), and -$226000.0 (Q3 2023), per Business Quant data.